LUNG Similar Chart Price Prediction
The price of LUNG is predicted to go up 0.33%, based on the high correlation periods with GJT. The similarity of these two price pattern on the periods is 94.47%.
LUNG
GJT
Up: 0.33%Similarity: 94.47%
LUNG Revenue Forecast
LUNG EPS Forecast
LUNG FAQs
What is LUNG revenue forecast for next quarter？
What is LUNG eps forecast for next quarter？
LUNG Analyst's Forecast
Jason Kolbert
D. Boral Capital
Strong Buy
2025-03-11
Price Target
$17
Upside
+132.88%
D. Boral Capital initiated coverage of Pulmonx with a Buy rating and $17 price target. The firm says Pulmonx is a commercial-stage medical technology company developing minimally invasive treatments for severe emphysema, a form of chronic obstructive pulmonary disease. With increasing physician adoption of the company's Zephyr Endobronchial Valve, strong reimbursement tailwinds, and international expansion opportunities, Pulmonx is well positioned for "significant growth," the analyst tells investors in a research note.
Jason Kolbert
D. Boral Capital
Strong Buy
2025-03-10
Price Target
$17
Upside
+135.62%
Joanne Wuensch
Citigroup
Strong Buy → Hold
2024-12-11
Price Target
$17 → $7.5
Upside
+17.37%
